Home
Live Updates
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting® : comparemela.com
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
--Poster highlights potential of oral small molecule IFNAR agonist program to engage the IFNα pathway through a liver-focused approach to improve tolerability-- SOUTH SAN FRANCISCO, Calif., Nov. ...
Related Keywords
Boston ,
Massachusetts ,
United States ,
William Delaney ,
Shannon Ryan ,
Alliance Management ,
Assembly Biosciences ,
Nasdaq ,
Securities Exchange ,
Exchange Commission ,
Assembly Biosciences Inc ,
Risk Factors In Assembly Bio ,
Assembly Bio ,
Corporate Affairs ,
Sam Brown Inc ,
American Association ,
Liver Diseases ,
Arbutus Biopharma ,
Vivo Profiling ,
Mimicking Interferon ,
Off Treatment Responses Following ,
Reverse Transcriptase Inhibitor ,
Analysis From ,
Open Label Phase ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
Investor Relations ,
Markets ,
comparemela.com © 2020. All Rights Reserved.